{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:32:31Z","timestamp":1785353551757,"version":"3.55.0"},"reference-count":17,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"unspecified","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Singapore Gastric Cancer Consortium"},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["OFLCG18May-0023"],"award-info":[{"award-number":["OFLCG18May-0023"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"crossref","award":["NMRC\/MOH\/000627"],"award-info":[{"award-number":["NMRC\/MOH\/000627"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2022,4,7]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:p>Immune checkpoint inhibition (ICI) is an established therapeutic option for patients with deficient mismatch repair or high levels of microsatellite instability tumors. Yet, response to ICI among this group is varied, with nearly one-third of patients exhibiting primary resistance. Initial efforts in studying mechanisms of resistance to ICI have focused on intrinsic tumor factors. Host factors such as metastatic niches have unique biological properties that may mediate resistance to ICI but have been less studied date. Patients with metastatic d-MMR\/MSI-H gastrointestinal cancers and peritoneal metastases (PM) who had concurrent ascites have been recently shown to have worse outcomes with ICI therapy compared with patients with PM without ascites and patients with non-PM metastases. The juxtaposition of tumors with an intrinsic sensitivity to ICI failing to respond by virtue of the presence of ascites within the peritoneum, brings to the forefront the critical role of the metastatic niche. In this commentary, we discuss mechanisms for ICI resistance that may arise from the immunoprivileged state of the peritoneal cavity, paracrine factors within malignant ascites or tumor-peritoneum interactions. An improved understanding of the peritoneal microenvironment and the use of peritoneal-directed therapies may ameliorate the modest benefit of ICIs in this unique clinical entity.<\/jats:p>","DOI":"10.1136\/jitc-2022-004749","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T11:21:43Z","timestamp":1655810503000},"page":"e004749","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Resistance to systemic immune checkpoint inhibition in the peritoneal niche"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct03172416","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Daryl Kai Ann","family":"Chia","sequence":"first","affiliation":[{"name":"Department of Surgery, University Surgical Cluster, National University Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Xiang","family":"Gwee","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9423-1368","authenticated-orcid":false,"given":"Raghav","family":"Sundar","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore"},{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore"},{"name":"The N.1 Institute for Health, National University of Singapore, Singapore"},{"name":"Singapore Gastric Cancer Consortium, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"2025100311063148000_10.6.e004749.1","article-title":"Landscape of microsatellite instability across 39 cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"2025100311063148000_10.6.e004749.2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4070"},{"key":"2025100311063148000_10.6.e004749.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017699"},{"key":"2025100311063148000_10.6.e004749.4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112638","article-title":"Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers","volume":"13","author":"Amodio","year":"2021","journal-title":"Cancers"},{"key":"2025100311063148000_10.6.e004749.5","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1539613","article-title":"Blockade of TGF-\u03b2 signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models","volume":"8","author":"Newsted","year":"2019","journal-title":"Oncoimmunology"},{"key":"2025100311063148000_10.6.e004749.6","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-1198"},{"key":"2025100311063148000_10.6.e004749.7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau0447"},{"key":"2025100311063148000_10.6.e004749.8","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2017-0010."},{"key":"2025100311063148000_10.6.e004749.9","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cort\u00e9s-Guiral","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025100311063148000_10.6.e004749.10","article-title":"Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis","author":"Gwee","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025100311063148000_10.6.e004749.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.09.011"},{"key":"2025100311063148000_10.6.e004749.12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.immuni.2019.05.010","article-title":"A stromal niche defined by expression of the transcription factor WT1 mediates programming and homeostasis of Cavity-Resident macrophages","volume":"51","author":"Buechler","year":"2019","journal-title":"Immunity"},{"key":"2025100311063148000_10.6.e004749.13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ccell.2021.05.006","article-title":"Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T\u00a0cell immunity","volume":"39","author":"Chow","year":"2021","journal-title":"Cancer Cell"},{"key":"2025100311063148000_10.6.e004749.14","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004001"},{"key":"2025100311063148000_10.6.e004749.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31827-5"},{"key":"2025100311063148000_10.6.e004749.16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2022.40.4_suppl.240","article-title":"Nivolumab (NIVO) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer\/gastroesophageal junction cancer\/esophageal adenocarcinoma (GC\/GEJC\/EAC): expanded efficacy, safety, and subgroup analyses from CheckMate 649","volume":"40","author":"Shitara","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025100311063148000_10.6.e004749.17","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.7308"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2022-004749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T18:06:38Z","timestamp":1759514798000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2022-004749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,21]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/jitc-2022-004749"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2022-004749","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}